Skip to main content
. 2010 Mar;209(1):42–50. doi: 10.1016/j.atherosclerosis.2009.09.070

Table 1.

Characteristics of the Caucasian 2 diabetes cases and controls.

UDACS T2D cases N = 569 EARSII controls N = 81 HIFMECH controls N = 367
Age (years), median [range] 68 [24–92] 21 [18–28] 53 [40–61]
Age of T2D onset (years) 55 (13)



Duration of T2D (years)a 9 [4–16]
 % Males (N) 59.4 (338) 100 (81) 100 (367)
 % Females (N) 40.6 (231) 0 (0) 0 (0)



% Females >50 years (N) 94.4 (218)
 BMI (kg/m2)b 29.3 (5.5) 23.0 (2.4) 25.6 (3.1)
 SBP (mmHg)b 140.5 (20.9) 112.6 (9.8) 127.1 (15.3)
 DBP (mmHg)b 79.3 (11.4) 66.0 (7.6) 82.8 (8.0)



Total cholesterol (mmol/l)b 4.96 (1.09) 4.06 (0.70) 5.50 (0.96)
 TG (mmol/l)b 1.92 (1.08) 0.93 (0.35) 1.40 (0.60)
 HDL (mmol/l)b 1.28 (0.37) 1.17 (0.20)
 LDL (mmol/l)c 2.71 (0.94) 2.38 (0.60)
 CRP (mg/l)b 1.72 (1.49) 0.59 (0.68) 1.08 (1.38)
 TAOS (%)a 44.7 [35.4–52.4]



Glucose (mmol/l)b 9.8 (4.3) 5.20 (0.37)
 HBA1c (%)b 7.65 (1.61)
% Hypertension (N) 83.4 (472) 0 (0) 4.2 (15)
% Ex/current smokers (N) 52.3 (291) 38.3 (31) 60.8 (223)



Hypoglycaemics
 % None (N) 11.2 (63)
 % Insulin (N) 13.1 (74) 0 (0) 0 (0)
 % Oral (N) 62.6 (353)
 % Both (N) 13.1 (74)



% BP lowering drug use (N) 68.6 (387) 0 (0) 0 (0)
 % Aspirin use (N) 50.6 (285) 0 (0) 0 (0)
 % Statin use (N) 31.6 (177) 0 (0) 0 (0)



Telomere length (kb)d 6.94 (6.80–7.03) 8.27 (7.62–9.00) 7.58 (7.39–7.81)

TG: triglycerides, HDL: high density lipoprotein, LDL: density lipoprotein, BMI: body mass index, CRP: C-reactive protein, SBP: systolic blood pressure, DBP: diastolic blood pressure, TAOS: total antioxidant status.

a

Median [IQR] is presented.

b

Data were log-transformed and geometric mean (approx SD) is presented.

c

Data were square root transformed and square of mean (approx SD) is presented.

d

Data were log-transformed and the geometric mean (95%CI) was then used to calculate the corresponding telomere length in kb. Telomere length presented is age-adjusted.